Myopia Treatment Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
Description
Myopia Treatment Devices Market Summary
The global myopia treatment devices market is expected to increase from USD 11,929.71 million in 2024 to USD 18,056.36 million by 2032, reflecting strong and sustained growth.
The global myopia treatment devices market is growing at a CAGR of 8.26% during the forecast period from 2025 to 2032.
The market of myopia treatment devices is being primarily driven by the rising prevalence of myopia and high myopia, technological advancements in vision correction devices, growing awareness of early intervention & preventive care, and an increase in product development activities among the key market players.
The leading companies operating in the myopia treatment devices market include CooperVision (CooperCompanies), Johnson & Johnson Services Inc., Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes, SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark'ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., Esahorus srl, Falco lenses AG, and others.
North America is expected to dominate the myopia treatment devices market due to the rising prevalence of refractive errors, strong adoption of advanced technologies such as excimer and femtosecond lasers, and high awareness regarding early intervention. The presence of leading manufacturers, well-established healthcare infrastructure, favorable reimbursement policies, and increasing demand for premium contact lenses and corrective solutions further strengthen the region’s market position.
In the product type segment of the myopia treatment devices market, the glasses category is estimated to account for the largest market share in 2024.
Factors Contributing to the Growth of the Myopia Treatment Devices Market
Rising prevalence of myopia and high myopia leading to a surge in myopia treatment devices: The rising prevalence of myopia and high myopia is driving a significant surge in demand for myopia treatment devices. With increasing screen time, reduced outdoor activity, and lifestyle changes, cases of myopia are escalating, particularly among children and young adults. This growing patient pool is fueling the adoption of corrective solutions such as eyeglasses, contact lenses, and orthokeratology lenses, along with advanced surgical options like laser systems and phakic intraocular lenses. As the risk of vision-threatening complications linked to high myopia becomes more evident, healthcare professionals and patients are increasingly turning to effective treatment devices, thereby boosting market growth.
Technological advancements in vision correction devices escalating the market of myopia treatment devices: Technological advancements in vision correction devices are escalating the market for myopia treatment devices by offering safer, more precise, and effective solutions. Innovations such as next-generation contact lenses for myopia control, advanced orthokeratology designs, and high-precision excimer and femtosecond laser systems are improving patient outcomes and expanding treatment options. These breakthroughs are enhancing adoption rates and driving overall market growth.
Growing awareness of early intervention & preventive care: Growing awareness of early intervention and preventive care is boosting the myopia treatment devices market as patients and healthcare providers increasingly recognize the importance of managing myopia at an early stage. With rising knowledge about the risks of high myopia and associated complications, demand for solutions such as orthokeratology lenses, atropine delivery systems, and specialty contact lenses is expanding. Educational campaigns, school screening programs, and proactive clinical recommendations are further driving the adoption of preventive devices to slow progression and protect long-term eye health.
Myopia Treatment Devices Market Report Segmentation
This myopia treatment devices market report offers a comprehensive overview of the global myopia treatment devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Corrective Lens {Contact Lenses [Soft Contact Lenses, Rigid Gas Permeable Contact Lenses, Ortho-K Lenses, and Others]}, Glasses (Spectacles), and Phakic Intraocular Lenses), Laser Based Refractive Surgery Devices [Excimer Laser System and Femtosecond Laser Systems]), End-User (Hospitals, Specialty Clinics, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing myopia treatment devices market.
Myopia treatment devices are a diverse range of medical technologies, products, and interventions designed to address nearsightedness (myopia). These devices can be categorized based on their primary function: correcting vision, slowing the progression of myopia (especially in children), or providing a permanent solution through surgery.
The overall market for myopia treatment devices is being boosted by the rising prevalence of myopia and high myopia, which is creating a larger patient base in need of corrective solutions. At the same time, technological advancements in vision correction devices are providing safer and more effective options, while growing awareness of early intervention and preventive care is driving demand for specialized lenses and treatments to control progression. Additionally, increased product development activities by key market players are expanding the availability of innovative devices, collectively accelerating market growth.
Get More Insights into the Report @Myopia Treatment Devices Market
What are the latest Myopia Treatment Devices Market Dynamics and Trends?
The global market for myopia treatment devices is experiencing significant growth, driven by two key factors: the rising worldwide prevalence of myopia and continuous technological innovation in product design.
Myopia is escalating into a global health concern. Recent data indicate a concerning trend, with projections suggesting that the current 31% of the population affected by myopia could increase to nearly 51% by 2050, impacting an estimated 5.5 billion people worldwide. This growing burden is fuelled by modern lifestyles, including increased screen time and reduced outdoor activity, and is accelerating the demand for a wide range of treatment options. While traditional solutions like eyeglasses, contact lenses, and orthokeratology lenses are in high demand, advanced surgical options, including excimer and femtosecond lasers, and phakic intraocular lenses, are also gaining popularity. The urgency for these interventions is further amplified by the serious risks associated with high myopia, such as retinal detachment, glaucoma, and cataracts.
In parallel, technological advancements are revolutionizing the market by offering safer, more precise, and more effective solutions. Innovations in next-generation contact lenses for myopia control, advanced orthokeratology lenses, and high-precision laser systems are expanding treatment possibilities. A prime example is the U.S. FDA's January 2025 approval of the ZEISS MEL 90 Excimer Laser, which demonstrates significant improvements in LASIK surgery. The system's advanced eye-tracker and high-speed laser ensure unparalleled precision and faster recovery times, highlighting the industry's commitment to enhancing patient outcomes. The FDA is also working to approve other products, such as low-dose atropine eye drops from Sydnexis, which would be the first FDA-approved pharmaceutical option for pediatric myopia in the United States.
This combination of rising myopia cases and technological progress is expected to drive the market forward from 2025 to 2032. However, some challenges may temper this growth. The potential risks and side effects of surgical procedures, such as dry eyes and vision quality issues, can be a deterrent for some patients. Furthermore, the stringent and time-consuming regulatory processes required for new product approvals may hinder the pace of innovation and market entry. The high cost of advanced treatments can also present a significant barrier to access for many individuals. Finally, a shortage of skilled eye care professionals specializing in myopia management could limit the widespread adoption of these advanced and complex treatments.
Myopia Treatment Devices Market Segment Analysis
Myopia Treatment Devices Market by Product Type (Corrective Lens {Contact Lenses [Soft Contact Lenses, Rigid Gas Permeable Contact Lenses, Ortho-K Lenses and Others]}, Glasses (Spectacles), and Phakic Intraocular Lenses), Laser Based Refractive Surgery Devices [Excimer Laser System and Femtosecond Laser Systems]), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
By Product Type: Corrective Lens Category Dominates the Market
In the corrective lens segment of the myopia treatment devices market, glasses (spectacles) are projected to hold the largest market share of 41% in 2024. Firstly, spectacles remain the most accessible and affordable option for vision correction across all age groups and socioeconomic classes. Unlike contact lenses or surgical interventions, glasses involve a significantly lower upfront cost, require minimal maintenance, and do not entail recurring expenses for solutions or frequent replacements apart from routine prescription updates. This affordability and ease of use make them the preferred choice for a wide population base.
Secondly, spectacles are regarded as the safest non-invasive corrective solution for myopia, especially for children and adolescents. Surgical options such as LASIK are generally not recommended for younger patients, and contact lens use can pose compliance challenges as well as risks of eye infections and corneal complications. Parents often prefer spectacles for children due to their safety profile and reliability.
Third, continuous technological advancements in lens design, including anti-reflective coatings, blue-light filtering, and myopia control innovations such as Defocus Incorporated Multiple Segments (DIMS) and peripheral defocus lenses, have further enhanced the role of spectacles in both vision correction and myopia management. These advancements improve comfort, reduce digital eye strain, and help slow myopia progression, which is especially critical given the rising prevalence of childhood myopia worldwide. Notably, in April 2024, HOYA expanded its MiYOSMART clear spectacle lens range, making them available for higher prescriptions (up to -13.00 D) and larger cylindrical powers, while also improving edge thickness and frame compatibility. This development extends access to children with high myopia and strengthens the clinical appeal of spectacle lenses for broader patient groups.
Additionally, spectacles benefit from widespread availability through both offline and online retail channels, ensuring strong adoption in developed as well as emerging markets. The rapid growth of e-commerce platforms and the increasing number of affordable vision care initiatives in developing regions further support their dominance.
Thus, cultural acceptance and lifestyle convenience continue to play a major role. Spectacles are easy to use, customizable in frame styles and aesthetics, and often double as fashion accessories, appealing to both younger and older demographics.
Taken together, these factors ensure that glasses (spectacles) will continue to command the largest market share in 2024 within the corrective lens segment, even as contact lenses and refractive surgical procedures see increasing adoption.
By End-User: Hospitals Dominate the Market
Hospitals are playing a crucial role in boosting the myopia treatment devices market by serving as primary centers for diagnosis, treatment, and management of myopia. Equipped with advanced diagnostic tools and surgical systems, hospitals provide access to laser eye surgeries, Phakic intraocular lens implantation, and orthokeratology treatments, which require professional supervision and follow-up care. They also facilitate early detection through routine eye exams and school screening programs, helping identify children at risk of progressive myopia. Moreover, hospitals act as key distribution channels for corrective devices such as eyeglasses, contact lenses, and specialty myopia control lenses. Their endorsement and recommendation of advanced treatment options increase patient trust and adoption rates, while collaborations with manufacturers for clinical trials and product launches further drive market growth. Overall, hospitals play a pivotal role in both delivering myopia treatment and educating patients, thereby significantly contributing to the expansion of the myopia treatment devices market.
Myopia Treatment Devices Market Regional Analysis
North America Myopia Treatment Devices Market Trends
North America is projected to have the largest share 34% of the myopia treatment devices market in 2024, driven by a combination of a high prevalence of refractive errors, a strong healthcare infrastructure, and continuous technological advancements. The region's market is also bolstered by high public awareness of eye care and favorable reimbursement policies, which encourage the use of advanced treatment options.
High Patient Pool and Demographics
The United States, in particular, represents a significant market, with an estimated myopia prevalence of 42.5% in 2024, according to a 2024 report by DelveInsight Business Research LLP. This large patient pool is further expanding due to the aging population, which is more susceptible to vision-related complications. As the number of older adults increases, so does the demand for various corrective solutions, ranging from eyeglasses and contact lenses to surgical interventions like excimer and femtosecond laser systems.
Technological Innovation
The market is also being propelled by ongoing research and product development. A prime example is the March 2025 U.S. launch of the Arise system by Bausch + Lomb. This cloud-based technology simplifies the design of orthokeratology lenses, including the first FDA-approved ortho-K lenses with toric peripheral curves. This innovation makes overnight myopia treatment more precise and accessible, contributing to the growth of the market in the region.
Europe Myopia Treatment Devices Market Trends
Europe is a significant force in the growth of the myopia treatment devices market, thanks to its advanced healthcare infrastructure, high public awareness, and rapid adoption of new technologies. The region boasts a strong network of ophthalmic clinics that provide a wide range of treatment options, from traditional eyeglasses and contact lenses to advanced laser-based procedures and innovative myopia control products.
Favorable Policies and High Demand
A key driver of the market in Europe is the rising prevalence of myopia, especially among children and young adults. This is being met with proactive government initiatives that promote eye health and regular vision screenings. A notable example is France, which in June 2025 became the first EU country to offer reimbursement for HOYA's MiYOSMART spectacle lenses. This policy change makes advanced myopia management more accessible to children aged 5 to 16 with high or rapidly progressive myopia, directly stimulating market demand.
Innovation and Research
The European market is also characterized by a strong presence of leading manufacturers and robust research and development activities. This has led to the introduction of advanced products like myopia control lenses and high-precision laser systems. The region's high patient awareness regarding the importance of early intervention, combined with a willingness to embrace new treatments, positions Europe as a crucial contributor to the overall expansion of the global myopia treatment devices market.
Asia-Pacific Myopia Treatment Devices Market Trends
The Asia-Pacific region is emerging as a key growth driver in the myopia treatment devices market due to the rapidly increasing prevalence of myopia, particularly among children and young adults in countries such as China, Japan, South Korea, and India. Factors such as prolonged screen time, intensive educational demands, and limited outdoor activity have contributed to a significant rise in nearsightedness, creating a large patient pool in need of corrective and preventive solutions. For instance, as per the recent studies, China and Japan have a prevalence of myopia of 80 to 90%.
Therefore, the region is witnessing growing adoption of eyeglasses, contact lenses, orthokeratology lenses, and advanced surgical options, supported by expanding healthcare infrastructure and increasing access to ophthalmic care. Rising awareness among parents and healthcare professionals about early intervention, coupled with government initiatives and school screening programs, is further driving demand. Additionally, the presence of leading global and regional manufacturers, along with ongoing product innovations such as myopia control lenses and precision laser systems, is accelerating market growth. Overall, the combination of high disease prevalence, technological advancements, and increasing healthcare accessibility positions the Asia-Pacific region as a significant contributor to the expansion of the myopia treatment devices market.
Who are the major players in the myopia treatment devices market?
The following are the leading companies in the myopia treatment devices market. These companies collectively hold the largest market share and dictate industry trends.
CooperVision (CooperCompanies)
Johnson & Johnson Services Inc.
Essilor
Bausch & Lomb Incorporated
Menicon Co., Ltd.
LUCID KOREA LTD.
Alcon Inc.
HOYA VISION CARE COMPANY
SynergEyes
SightGlass Vision, Inc.
Ophtec BV
STAAR SURGICAL
Mark'ennovy
SCHWIND eye-tech-solutions
Euclid Systems Corporation
NIDEK USA, Inc.
Esahorus srl
Falco lenses AG
Others
How is the competitive landscape shaping the Myopia Treatment Devices market?
The competitive landscape of the myopia treatment devices market is characterized by a moderate concentration, with several key players leading innovation and market share. Major companies such as EssilorLuxottica, Johnson & Johnson Vision, CooperVision, Bausch + Lomb, Carl Zeiss Meditec, Alcon, Hoya Vision Care, Nidek Co., Ltd., and Ziemer Ophthalmic Systems AG dominate the market. These industry leaders are actively engaged in research and development to introduce advanced myopia management solutions, including innovative contact lenses, orthokeratology lenses, surgical systems, and pharmacological treatments. For instance, Bausch + Lomb launched the Arise lens fitting system, integrating cloud-based technology to streamline orthokeratology lens design. The market's moderate concentration indicates a competitive environment where established companies leverage technological advancements and strategic partnerships to maintain and expand their market presence. This dynamic fosters continuous innovation and improved treatment options for myopia, benefiting patients and healthcare providers alike.
Recent Developmental Activities in the Myopia Treatment Devices Market
In August 2025, CooperVision had gained approval from Japan’s Ministry of Health, Labor and Welfare for the manufacture and sale of its MiSight® 1-day contact lenses, making it the first soft lens in the country authorized for use by children to correct myopia and control its progression.
In June 2025, France became the first country in the EU to offer reimbursement for HOYA MiYOSMART spectacle lenses for myopia management. Children aged 5 to 16 with high and/or rapidly progressive myopia are now eligible to receive MiYOSMART lenses on a reimbursement basis.
In March 2025, Bausch + Lomb Corporation announced the U.S. launch of Arise, a lens fitting system using cloud-based technology to streamline orthokeratology lens design. Arise synced with topographers to create precise lens designs in seconds and included the first FDA-approved ortho-K lenses with toric peripheral curves to treat myopia overnight.
In January 2025, ZEISS Medical Technology announced that the MEL® 90 received U.S. Food and Drug Administration (FDA) approval, giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia, and mixed astigmatism.
In January 2024, ZEISS announced the FDA approval of its VisuMax 800 with SMILE Pro software to surgically treat nearsightedness, with or without astigmatism.
In January 2024, Bausch + Lomb Corporation announced that the U.S. FDA had approved the TENEO Excimer Laser Platform for LASIK vision correction surgery for myopia and myopic astigmatism. The system featured a 1,740Hz eye-tracker, operating over three times faster than the laser’s repetition rate, ensuring precise ablation despite eye movement. Its high-speed 500Hz laser delivered the fastest ablation time in the U.S., at about 1.2 seconds per diopter, supporting improved post-operative outcomes.
In March 2022, STAAR Surgical Company announced that the U.S. Food and Drug Administration (FDA) had granted approval of the EVO/EVO+ Visian® Implantable Collamer® Lens (“EVO”) for the correction of myopia and myopia with astigmatism.
Myopia Treatment Devices Market Segmentation
Myopia Treatment Devices by Product Type Exposure
Soft Contact Lenses
Rigid Gas Permeable Contact Lenses
Ortho-K Lenses
Others
Glasses (spectacles)
Phakic Intraocular Lenses
Femtosecond Laser Systems
Myopia Treatment Devices End-Users Exposure
Canada Myopia Treatment Devices Market
Mexico Myopia Treatment Devices Market
Germany Myopia Treatment Devices Market
France Myopia Treatment Devices Market
Italy Myopia Treatment Devices Market
Spain Myopia Treatment Devices Market
Rest of Europe Myopia Treatment Devices Market
Japan Myopia Treatment Devices Market
India Myopia Treatment Devices Market
Australia Myopia Treatment Devices Market
South Korea Myopia Treatment Devices Market
Rest of Asia-Pacific Myopia Treatment Devices Market
Middle East Myopia Treatment Devices Market
Africa Myopia Treatment Devices Market
Impact Analysis
AI-Powered Innovations and Applications:
AI-powered innovations are increasingly transforming the landscape of myopia treatment devices by enabling more personalized, precise, and predictive care. Advanced AI algorithms are being integrated into diagnostic devices such as optical coherence tomography (OCT) and wavefront analyzers to detect early signs of myopia progression and quantify axial length changes with high accuracy. AI is also applied in smart contact lenses and orthokeratology (Ortho-K) lens design, where machine learning models analyze corneal shape, eye growth patterns, and visual behavior to create customized lenses that slow myopia progression effectively. Furthermore, AI-driven software platforms assist eye care professionals in risk stratification, patient monitoring, and treatment planning, providing predictive insights on the likelihood of myopia worsening in children. Teleophthalmology platforms powered by AI are enabling remote monitoring of myopic patients, integrating real-time data from wearable devices and smart lenses to adjust treatment plans dynamically. Overall, these AI-powered innovations enhance early detection, individualized treatment, and continuous monitoring, driving improved outcomes in myopia management.
U.S. Tariff Impact Analysis on Myopia Treatment Devices Market:
The U.S. tariff landscape has significantly impacted the myopia treatment devices market, particularly concerning imports from China, which is a key supplier of ophthalmic products. As of August 2025, several countries, including China, face elevated tariffs on optical goods. For instance, plastic eyeglass frames and related accessories imported from China are subject to a combined tariff rate of approximately 155%, encompassing base duties, Section 301 tariffs, and reciprocal duties under the International Emergency Economic Powers Act (IEEPA).
This tariff escalation has led to increased costs for myopia treatment devices, such as orthokeratology lenses and specialized contact lenses, which are often sourced from countries like China, Taiwan, and the Netherlands. The elevated import duties have disrupted supply chains, delayed product availability, and strained the affordability of these essential vision correction tools, especially for pediatric patients.
In response to these challenges, industry stakeholders, including The Vision Council, have engaged with policymakers to advocate for exemptions or reductions in tariffs on medical and vision-related products. Despite these efforts, the ongoing trade tensions and tariff implementations continue to pose significant hurdles for the myopia treatment devices market in the U.S.
How This Analysis Helps Clients
Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
Key takeaways from the Myopia Treatment Devices market report study
Market size analysis for the current myopia treatment devices market size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
Key companies dominating the myopia treatment devices market.
Various opportunities available for the other competitors in the myopia treatment devices market space.
What are the top-performing segments in 2024How these segments will perform in 2032?
Which are the top-performing regions and countries in the current myopia treatment devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for the myopia treatment devices market growth in the future?
Frequently Asked Questions for the Myopia Treatment Devices Market
1. What is the growth rate of the myopia treatment devices market?
The myopia treatment devices market is estimated to grow at a CAGR of 8.26% during the forecast period from 2025 to 2032.
2. What is the market for myopia treatment devices?
The myopia treatment devices market was valued at USD 11,929.71 million in 2024, and is expected to reach USD 18,056.36 million by 2032.
3. Which region has the highest share in the myopia treatment devices market?
North America is expected to dominate the myopia treatment devices market due to the rising prevalence of refractive errors, strong adoption of advanced technologies such as excimer and femtosecond lasers, and high awareness regarding early intervention. The presence of leading manufacturers, well-established healthcare infrastructure, favorable reimbursement policies, and increasing demand for premium contact lenses and corrective solutions further strengthen the region’s market position.
4. What are the drivers for the myopia treatment devices market?
The overall market for myopia treatment devices is being boosted by the rising prevalence of myopia and high myopia, which is creating a larger patient base in need of corrective solutions. At the same time, technological advancements in vision correction devices are providing safer and more effective options, while growing awareness of early intervention and preventive care is driving demand for specialized lenses and treatments to control progression. Additionally, increased product development activities by key market players are expanding the availability of innovative devices, collectively accelerating market growth.
5. Who are the key players operating in the myopia treatment devices market?
Some of the key market players operating in the myopia treatment devices market include CooperVision (CooperCompanies), Johnson & Johnson Services Inc., Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes, SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark'ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., Esahorus srl, Falco lenses AG, and others.
The global myopia treatment devices market is expected to increase from USD 11,929.71 million in 2024 to USD 18,056.36 million by 2032, reflecting strong and sustained growth.
The global myopia treatment devices market is growing at a CAGR of 8.26% during the forecast period from 2025 to 2032.
The market of myopia treatment devices is being primarily driven by the rising prevalence of myopia and high myopia, technological advancements in vision correction devices, growing awareness of early intervention & preventive care, and an increase in product development activities among the key market players.
The leading companies operating in the myopia treatment devices market include CooperVision (CooperCompanies), Johnson & Johnson Services Inc., Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes, SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark'ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., Esahorus srl, Falco lenses AG, and others.
North America is expected to dominate the myopia treatment devices market due to the rising prevalence of refractive errors, strong adoption of advanced technologies such as excimer and femtosecond lasers, and high awareness regarding early intervention. The presence of leading manufacturers, well-established healthcare infrastructure, favorable reimbursement policies, and increasing demand for premium contact lenses and corrective solutions further strengthen the region’s market position.
In the product type segment of the myopia treatment devices market, the glasses category is estimated to account for the largest market share in 2024.
Factors Contributing to the Growth of the Myopia Treatment Devices Market
Rising prevalence of myopia and high myopia leading to a surge in myopia treatment devices: The rising prevalence of myopia and high myopia is driving a significant surge in demand for myopia treatment devices. With increasing screen time, reduced outdoor activity, and lifestyle changes, cases of myopia are escalating, particularly among children and young adults. This growing patient pool is fueling the adoption of corrective solutions such as eyeglasses, contact lenses, and orthokeratology lenses, along with advanced surgical options like laser systems and phakic intraocular lenses. As the risk of vision-threatening complications linked to high myopia becomes more evident, healthcare professionals and patients are increasingly turning to effective treatment devices, thereby boosting market growth.
Technological advancements in vision correction devices escalating the market of myopia treatment devices: Technological advancements in vision correction devices are escalating the market for myopia treatment devices by offering safer, more precise, and effective solutions. Innovations such as next-generation contact lenses for myopia control, advanced orthokeratology designs, and high-precision excimer and femtosecond laser systems are improving patient outcomes and expanding treatment options. These breakthroughs are enhancing adoption rates and driving overall market growth.
Growing awareness of early intervention & preventive care: Growing awareness of early intervention and preventive care is boosting the myopia treatment devices market as patients and healthcare providers increasingly recognize the importance of managing myopia at an early stage. With rising knowledge about the risks of high myopia and associated complications, demand for solutions such as orthokeratology lenses, atropine delivery systems, and specialty contact lenses is expanding. Educational campaigns, school screening programs, and proactive clinical recommendations are further driving the adoption of preventive devices to slow progression and protect long-term eye health.
Myopia Treatment Devices Market Report Segmentation
This myopia treatment devices market report offers a comprehensive overview of the global myopia treatment devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Corrective Lens {Contact Lenses [Soft Contact Lenses, Rigid Gas Permeable Contact Lenses, Ortho-K Lenses, and Others]}, Glasses (Spectacles), and Phakic Intraocular Lenses), Laser Based Refractive Surgery Devices [Excimer Laser System and Femtosecond Laser Systems]), End-User (Hospitals, Specialty Clinics, and Others), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing myopia treatment devices market.
Myopia treatment devices are a diverse range of medical technologies, products, and interventions designed to address nearsightedness (myopia). These devices can be categorized based on their primary function: correcting vision, slowing the progression of myopia (especially in children), or providing a permanent solution through surgery.
The overall market for myopia treatment devices is being boosted by the rising prevalence of myopia and high myopia, which is creating a larger patient base in need of corrective solutions. At the same time, technological advancements in vision correction devices are providing safer and more effective options, while growing awareness of early intervention and preventive care is driving demand for specialized lenses and treatments to control progression. Additionally, increased product development activities by key market players are expanding the availability of innovative devices, collectively accelerating market growth.
Get More Insights into the Report @Myopia Treatment Devices Market
What are the latest Myopia Treatment Devices Market Dynamics and Trends?
The global market for myopia treatment devices is experiencing significant growth, driven by two key factors: the rising worldwide prevalence of myopia and continuous technological innovation in product design.
Myopia is escalating into a global health concern. Recent data indicate a concerning trend, with projections suggesting that the current 31% of the population affected by myopia could increase to nearly 51% by 2050, impacting an estimated 5.5 billion people worldwide. This growing burden is fuelled by modern lifestyles, including increased screen time and reduced outdoor activity, and is accelerating the demand for a wide range of treatment options. While traditional solutions like eyeglasses, contact lenses, and orthokeratology lenses are in high demand, advanced surgical options, including excimer and femtosecond lasers, and phakic intraocular lenses, are also gaining popularity. The urgency for these interventions is further amplified by the serious risks associated with high myopia, such as retinal detachment, glaucoma, and cataracts.
In parallel, technological advancements are revolutionizing the market by offering safer, more precise, and more effective solutions. Innovations in next-generation contact lenses for myopia control, advanced orthokeratology lenses, and high-precision laser systems are expanding treatment possibilities. A prime example is the U.S. FDA's January 2025 approval of the ZEISS MEL 90 Excimer Laser, which demonstrates significant improvements in LASIK surgery. The system's advanced eye-tracker and high-speed laser ensure unparalleled precision and faster recovery times, highlighting the industry's commitment to enhancing patient outcomes. The FDA is also working to approve other products, such as low-dose atropine eye drops from Sydnexis, which would be the first FDA-approved pharmaceutical option for pediatric myopia in the United States.
This combination of rising myopia cases and technological progress is expected to drive the market forward from 2025 to 2032. However, some challenges may temper this growth. The potential risks and side effects of surgical procedures, such as dry eyes and vision quality issues, can be a deterrent for some patients. Furthermore, the stringent and time-consuming regulatory processes required for new product approvals may hinder the pace of innovation and market entry. The high cost of advanced treatments can also present a significant barrier to access for many individuals. Finally, a shortage of skilled eye care professionals specializing in myopia management could limit the widespread adoption of these advanced and complex treatments.
Myopia Treatment Devices Market Segment Analysis
Myopia Treatment Devices Market by Product Type (Corrective Lens {Contact Lenses [Soft Contact Lenses, Rigid Gas Permeable Contact Lenses, Ortho-K Lenses and Others]}, Glasses (Spectacles), and Phakic Intraocular Lenses), Laser Based Refractive Surgery Devices [Excimer Laser System and Femtosecond Laser Systems]), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
By Product Type: Corrective Lens Category Dominates the Market
In the corrective lens segment of the myopia treatment devices market, glasses (spectacles) are projected to hold the largest market share of 41% in 2024. Firstly, spectacles remain the most accessible and affordable option for vision correction across all age groups and socioeconomic classes. Unlike contact lenses or surgical interventions, glasses involve a significantly lower upfront cost, require minimal maintenance, and do not entail recurring expenses for solutions or frequent replacements apart from routine prescription updates. This affordability and ease of use make them the preferred choice for a wide population base.
Secondly, spectacles are regarded as the safest non-invasive corrective solution for myopia, especially for children and adolescents. Surgical options such as LASIK are generally not recommended for younger patients, and contact lens use can pose compliance challenges as well as risks of eye infections and corneal complications. Parents often prefer spectacles for children due to their safety profile and reliability.
Third, continuous technological advancements in lens design, including anti-reflective coatings, blue-light filtering, and myopia control innovations such as Defocus Incorporated Multiple Segments (DIMS) and peripheral defocus lenses, have further enhanced the role of spectacles in both vision correction and myopia management. These advancements improve comfort, reduce digital eye strain, and help slow myopia progression, which is especially critical given the rising prevalence of childhood myopia worldwide. Notably, in April 2024, HOYA expanded its MiYOSMART clear spectacle lens range, making them available for higher prescriptions (up to -13.00 D) and larger cylindrical powers, while also improving edge thickness and frame compatibility. This development extends access to children with high myopia and strengthens the clinical appeal of spectacle lenses for broader patient groups.
Additionally, spectacles benefit from widespread availability through both offline and online retail channels, ensuring strong adoption in developed as well as emerging markets. The rapid growth of e-commerce platforms and the increasing number of affordable vision care initiatives in developing regions further support their dominance.
Thus, cultural acceptance and lifestyle convenience continue to play a major role. Spectacles are easy to use, customizable in frame styles and aesthetics, and often double as fashion accessories, appealing to both younger and older demographics.
Taken together, these factors ensure that glasses (spectacles) will continue to command the largest market share in 2024 within the corrective lens segment, even as contact lenses and refractive surgical procedures see increasing adoption.
By End-User: Hospitals Dominate the Market
Hospitals are playing a crucial role in boosting the myopia treatment devices market by serving as primary centers for diagnosis, treatment, and management of myopia. Equipped with advanced diagnostic tools and surgical systems, hospitals provide access to laser eye surgeries, Phakic intraocular lens implantation, and orthokeratology treatments, which require professional supervision and follow-up care. They also facilitate early detection through routine eye exams and school screening programs, helping identify children at risk of progressive myopia. Moreover, hospitals act as key distribution channels for corrective devices such as eyeglasses, contact lenses, and specialty myopia control lenses. Their endorsement and recommendation of advanced treatment options increase patient trust and adoption rates, while collaborations with manufacturers for clinical trials and product launches further drive market growth. Overall, hospitals play a pivotal role in both delivering myopia treatment and educating patients, thereby significantly contributing to the expansion of the myopia treatment devices market.
Myopia Treatment Devices Market Regional Analysis
North America Myopia Treatment Devices Market Trends
North America is projected to have the largest share 34% of the myopia treatment devices market in 2024, driven by a combination of a high prevalence of refractive errors, a strong healthcare infrastructure, and continuous technological advancements. The region's market is also bolstered by high public awareness of eye care and favorable reimbursement policies, which encourage the use of advanced treatment options.
High Patient Pool and Demographics
The United States, in particular, represents a significant market, with an estimated myopia prevalence of 42.5% in 2024, according to a 2024 report by DelveInsight Business Research LLP. This large patient pool is further expanding due to the aging population, which is more susceptible to vision-related complications. As the number of older adults increases, so does the demand for various corrective solutions, ranging from eyeglasses and contact lenses to surgical interventions like excimer and femtosecond laser systems.
Technological Innovation
The market is also being propelled by ongoing research and product development. A prime example is the March 2025 U.S. launch of the Arise system by Bausch + Lomb. This cloud-based technology simplifies the design of orthokeratology lenses, including the first FDA-approved ortho-K lenses with toric peripheral curves. This innovation makes overnight myopia treatment more precise and accessible, contributing to the growth of the market in the region.
Europe Myopia Treatment Devices Market Trends
Europe is a significant force in the growth of the myopia treatment devices market, thanks to its advanced healthcare infrastructure, high public awareness, and rapid adoption of new technologies. The region boasts a strong network of ophthalmic clinics that provide a wide range of treatment options, from traditional eyeglasses and contact lenses to advanced laser-based procedures and innovative myopia control products.
Favorable Policies and High Demand
A key driver of the market in Europe is the rising prevalence of myopia, especially among children and young adults. This is being met with proactive government initiatives that promote eye health and regular vision screenings. A notable example is France, which in June 2025 became the first EU country to offer reimbursement for HOYA's MiYOSMART spectacle lenses. This policy change makes advanced myopia management more accessible to children aged 5 to 16 with high or rapidly progressive myopia, directly stimulating market demand.
Innovation and Research
The European market is also characterized by a strong presence of leading manufacturers and robust research and development activities. This has led to the introduction of advanced products like myopia control lenses and high-precision laser systems. The region's high patient awareness regarding the importance of early intervention, combined with a willingness to embrace new treatments, positions Europe as a crucial contributor to the overall expansion of the global myopia treatment devices market.
Asia-Pacific Myopia Treatment Devices Market Trends
The Asia-Pacific region is emerging as a key growth driver in the myopia treatment devices market due to the rapidly increasing prevalence of myopia, particularly among children and young adults in countries such as China, Japan, South Korea, and India. Factors such as prolonged screen time, intensive educational demands, and limited outdoor activity have contributed to a significant rise in nearsightedness, creating a large patient pool in need of corrective and preventive solutions. For instance, as per the recent studies, China and Japan have a prevalence of myopia of 80 to 90%.
Therefore, the region is witnessing growing adoption of eyeglasses, contact lenses, orthokeratology lenses, and advanced surgical options, supported by expanding healthcare infrastructure and increasing access to ophthalmic care. Rising awareness among parents and healthcare professionals about early intervention, coupled with government initiatives and school screening programs, is further driving demand. Additionally, the presence of leading global and regional manufacturers, along with ongoing product innovations such as myopia control lenses and precision laser systems, is accelerating market growth. Overall, the combination of high disease prevalence, technological advancements, and increasing healthcare accessibility positions the Asia-Pacific region as a significant contributor to the expansion of the myopia treatment devices market.
Who are the major players in the myopia treatment devices market?
The following are the leading companies in the myopia treatment devices market. These companies collectively hold the largest market share and dictate industry trends.
CooperVision (CooperCompanies)
Johnson & Johnson Services Inc.
Essilor
Bausch & Lomb Incorporated
Menicon Co., Ltd.
LUCID KOREA LTD.
Alcon Inc.
HOYA VISION CARE COMPANY
SynergEyes
SightGlass Vision, Inc.
Ophtec BV
STAAR SURGICAL
Mark'ennovy
SCHWIND eye-tech-solutions
Euclid Systems Corporation
NIDEK USA, Inc.
Esahorus srl
Falco lenses AG
Others
How is the competitive landscape shaping the Myopia Treatment Devices market?
The competitive landscape of the myopia treatment devices market is characterized by a moderate concentration, with several key players leading innovation and market share. Major companies such as EssilorLuxottica, Johnson & Johnson Vision, CooperVision, Bausch + Lomb, Carl Zeiss Meditec, Alcon, Hoya Vision Care, Nidek Co., Ltd., and Ziemer Ophthalmic Systems AG dominate the market. These industry leaders are actively engaged in research and development to introduce advanced myopia management solutions, including innovative contact lenses, orthokeratology lenses, surgical systems, and pharmacological treatments. For instance, Bausch + Lomb launched the Arise lens fitting system, integrating cloud-based technology to streamline orthokeratology lens design. The market's moderate concentration indicates a competitive environment where established companies leverage technological advancements and strategic partnerships to maintain and expand their market presence. This dynamic fosters continuous innovation and improved treatment options for myopia, benefiting patients and healthcare providers alike.
Recent Developmental Activities in the Myopia Treatment Devices Market
In August 2025, CooperVision had gained approval from Japan’s Ministry of Health, Labor and Welfare for the manufacture and sale of its MiSight® 1-day contact lenses, making it the first soft lens in the country authorized for use by children to correct myopia and control its progression.
In June 2025, France became the first country in the EU to offer reimbursement for HOYA MiYOSMART spectacle lenses for myopia management. Children aged 5 to 16 with high and/or rapidly progressive myopia are now eligible to receive MiYOSMART lenses on a reimbursement basis.
In March 2025, Bausch + Lomb Corporation announced the U.S. launch of Arise, a lens fitting system using cloud-based technology to streamline orthokeratology lens design. Arise synced with topographers to create precise lens designs in seconds and included the first FDA-approved ortho-K lenses with toric peripheral curves to treat myopia overnight.
In January 2025, ZEISS Medical Technology announced that the MEL® 90 received U.S. Food and Drug Administration (FDA) approval, giving the excimer laser technology simultaneous approval for all three major indications, including myopia, hyperopia, and mixed astigmatism.
In January 2024, ZEISS announced the FDA approval of its VisuMax 800 with SMILE Pro software to surgically treat nearsightedness, with or without astigmatism.
In January 2024, Bausch + Lomb Corporation announced that the U.S. FDA had approved the TENEO Excimer Laser Platform for LASIK vision correction surgery for myopia and myopic astigmatism. The system featured a 1,740Hz eye-tracker, operating over three times faster than the laser’s repetition rate, ensuring precise ablation despite eye movement. Its high-speed 500Hz laser delivered the fastest ablation time in the U.S., at about 1.2 seconds per diopter, supporting improved post-operative outcomes.
In March 2022, STAAR Surgical Company announced that the U.S. Food and Drug Administration (FDA) had granted approval of the EVO/EVO+ Visian® Implantable Collamer® Lens (“EVO”) for the correction of myopia and myopia with astigmatism.
Myopia Treatment Devices Market Segmentation
Myopia Treatment Devices by Product Type Exposure
- Corrective Lenses
Soft Contact Lenses
Rigid Gas Permeable Contact Lenses
Ortho-K Lenses
Others
Glasses (spectacles)
Phakic Intraocular Lenses
- Laser Based Refractive Surgery Devices
Femtosecond Laser Systems
Myopia Treatment Devices End-Users Exposure
- Hospitals
- Specialty Clinics
- Others
- North America Myopia Treatment Devices Market
Canada Myopia Treatment Devices Market
Mexico Myopia Treatment Devices Market
- Europe Myopia Treatment Devices Market
Germany Myopia Treatment Devices Market
France Myopia Treatment Devices Market
Italy Myopia Treatment Devices Market
Spain Myopia Treatment Devices Market
Rest of Europe Myopia Treatment Devices Market
- Asia-Pacific Myopia Treatment Devices Market
Japan Myopia Treatment Devices Market
India Myopia Treatment Devices Market
Australia Myopia Treatment Devices Market
South Korea Myopia Treatment Devices Market
Rest of Asia-Pacific Myopia Treatment Devices Market
- Rest of the World Myopia Treatment Devices Market
Middle East Myopia Treatment Devices Market
Africa Myopia Treatment Devices Market
Impact Analysis
AI-Powered Innovations and Applications:
AI-powered innovations are increasingly transforming the landscape of myopia treatment devices by enabling more personalized, precise, and predictive care. Advanced AI algorithms are being integrated into diagnostic devices such as optical coherence tomography (OCT) and wavefront analyzers to detect early signs of myopia progression and quantify axial length changes with high accuracy. AI is also applied in smart contact lenses and orthokeratology (Ortho-K) lens design, where machine learning models analyze corneal shape, eye growth patterns, and visual behavior to create customized lenses that slow myopia progression effectively. Furthermore, AI-driven software platforms assist eye care professionals in risk stratification, patient monitoring, and treatment planning, providing predictive insights on the likelihood of myopia worsening in children. Teleophthalmology platforms powered by AI are enabling remote monitoring of myopic patients, integrating real-time data from wearable devices and smart lenses to adjust treatment plans dynamically. Overall, these AI-powered innovations enhance early detection, individualized treatment, and continuous monitoring, driving improved outcomes in myopia management.
U.S. Tariff Impact Analysis on Myopia Treatment Devices Market:
The U.S. tariff landscape has significantly impacted the myopia treatment devices market, particularly concerning imports from China, which is a key supplier of ophthalmic products. As of August 2025, several countries, including China, face elevated tariffs on optical goods. For instance, plastic eyeglass frames and related accessories imported from China are subject to a combined tariff rate of approximately 155%, encompassing base duties, Section 301 tariffs, and reciprocal duties under the International Emergency Economic Powers Act (IEEPA).
This tariff escalation has led to increased costs for myopia treatment devices, such as orthokeratology lenses and specialized contact lenses, which are often sourced from countries like China, Taiwan, and the Netherlands. The elevated import duties have disrupted supply chains, delayed product availability, and strained the affordability of these essential vision correction tools, especially for pediatric patients.
In response to these challenges, industry stakeholders, including The Vision Council, have engaged with policymakers to advocate for exemptions or reductions in tariffs on medical and vision-related products. Despite these efforts, the ongoing trade tensions and tariff implementations continue to pose significant hurdles for the myopia treatment devices market in the U.S.
How This Analysis Helps Clients
Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.
Key takeaways from the Myopia Treatment Devices market report study
Market size analysis for the current myopia treatment devices market size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
Key companies dominating the myopia treatment devices market.
Various opportunities available for the other competitors in the myopia treatment devices market space.
What are the top-performing segments in 2024How these segments will perform in 2032?
Which are the top-performing regions and countries in the current myopia treatment devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for the myopia treatment devices market growth in the future?
Frequently Asked Questions for the Myopia Treatment Devices Market
1. What is the growth rate of the myopia treatment devices market?
The myopia treatment devices market is estimated to grow at a CAGR of 8.26% during the forecast period from 2025 to 2032.
2. What is the market for myopia treatment devices?
The myopia treatment devices market was valued at USD 11,929.71 million in 2024, and is expected to reach USD 18,056.36 million by 2032.
3. Which region has the highest share in the myopia treatment devices market?
North America is expected to dominate the myopia treatment devices market due to the rising prevalence of refractive errors, strong adoption of advanced technologies such as excimer and femtosecond lasers, and high awareness regarding early intervention. The presence of leading manufacturers, well-established healthcare infrastructure, favorable reimbursement policies, and increasing demand for premium contact lenses and corrective solutions further strengthen the region’s market position.
4. What are the drivers for the myopia treatment devices market?
The overall market for myopia treatment devices is being boosted by the rising prevalence of myopia and high myopia, which is creating a larger patient base in need of corrective solutions. At the same time, technological advancements in vision correction devices are providing safer and more effective options, while growing awareness of early intervention and preventive care is driving demand for specialized lenses and treatments to control progression. Additionally, increased product development activities by key market players are expanding the availability of innovative devices, collectively accelerating market growth.
5. Who are the key players operating in the myopia treatment devices market?
Some of the key market players operating in the myopia treatment devices market include CooperVision (CooperCompanies), Johnson & Johnson Services Inc., Essilor, Bausch & Lomb Incorporated, Menicon Co., Ltd., LUCID KOREA LTD., Alcon Inc., HOYA VISION CARE COMPANY, SynergEyes, SightGlass Vision, Inc., Ophtec BV, STAAR SURGICAL, Mark'ennovy, SCHWIND eye-tech-solutions, Euclid Systems Corporation, NIDEK USA, Inc., Esahorus srl, Falco lenses AG, and others.
Table of Contents
150 Pages
- 1. Myopia Treatment Devices Market Report Introduction
- 1.1 Scope of the Study
- 1.2 Market Segmentation
- 1.3 Market Assumption
- 2. Myopia Treatment Devices Market Executive Summary
- 2.1 Market at Glance
- 3. Myopia Treatment Devices Market Key Factors Analysis
- 3.1 Myopia Treatment Devices Market Drivers
- 3.1.1 Rising prevalence of myopia and high myopia
- 3.1.2 Technological advancements in vision correction devices
- 3.1.3 Growing awareness of early intervention & preventive care
- 3.1.4 Increase in product development activities among the key market players
- 3.2 Myopia Treatment Devices Market Restraints and Challenges
- 3.2.1 The potential risks and side effects of surgical procedures
- 3.2.2 Stringent regulatory concerns for product approval
- 3.3 Myopia Treatment Devices Market Opportunity
- 3.3.1 Innovation of AI-powered lenses and overnight vision correction
- 4. Impact Analysis
- 4.1 AI-Powered Innovations and Applications
- 4.2 U.S. Tariff Impact Analysis
- 5. Regulatory Analysis
- 5.1 The United States
- 5.2 Europe
- 5.3 Japan
- 5.4 China
- 6. Myopia Treatment Devices Market Porter’s Five Forces Analysis
- 6.1 Bargaining Power of Suppliers
- 6.2 Bargaining Power of Consumers
- 6.3 Threat of New Entrants
- 6.4 Threat of Substitutes
- 6.5 Competitive Rivalry
- 7. Myopia Treatment Devices Market Assessment
- 7.1 By Product Type
- 7.1.1 Corrective Lens
- 7.1.1.1 Contact Lenses
- 7.1.1.1.1 Soft Contact Lenses
- 7.1.1.1.2 Rigid Gas Permeable Contact Lenses
- 7.1.1.1.3 Ortho-K Lenses
- 7.1.1.1.4 Others
- 7.1.1.2 Glasses (Spectacles)
- 7.1.1.3 Phakic Intraocular Lenses
- 7.1.2 Laser Based Refractive Surgery Devices
- 7.1.2.1 Excimer Laser System
- 7.1.2.2 Femtosecond Laser Systems
- 7.2 By End-Users
- 7.2.1 Hospitals
- 7.2.2 Specialty Clinics
- 7.2.3 Others
- 7.3 By Geography
- 7.3.1 North America
- 7.3.1.1 United States Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.1.2 Canada Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.1.3 Mexico Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.2 Europe
- 7.3.2.1 France Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.2.2 Germany Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.2.3 United Kingdom Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.2.4 Italy Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.2.5 Spain Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.2.6 Rest of Europe Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.3 Asia-Pacific
- 7.3.3.1 China Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.3.2 Japan Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.3.3 India Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.3.4 Australia Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.3.5 South Korea Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.3.6 Rest of Asia-Pacific Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.4 Rest of the World (RoW)
- 7.3.4.1 Middle East Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.4.2 Africa Myopia Treatment Devices Market Size in USD million (2022-2032)
- 7.3.4.3 South America Myopia Treatment Devices Market Size In USD Million (2022-2032)
- 8. Competitive Landscape
- 9. Startup Funding & Investment Trends
- 10. Myopia Treatment Devices Market Company and Product Profiles
- 10.1 CooperVision (CooperCompanies)
- 10.1.1 Company Overview
- 10.1.2 Company Snapshot
- 10.1.3 Financial Overview
- 10.1.4 Product Listing
- 10.1.5 Entropy
- 10.2 Johnson & Johnson Services Inc.
- 10.2.1 Company Overview
- 10.2.2 Company Snapshot
- 10.2.3 Financial Overview
- 10.2.4 Product Listing
- 10.2.5 Entropy
- 10.3 Essilor
- 10.3.1 Company Overview
- 10.3.2 Company Snapshot
- 10.3.3 Financial Overview
- 10.3.4 Product Listing
- 10.3.5 Entropy
- 10.4 Bausch & Lomb Incorporated
- 10.4.1 Company Overview
- 10.4.2 Company Snapshot
- 10.4.3 Financial Overview
- 10.4.4 Product Listing
- 10.4.5 Entropy
- 10.5 Menicon Co., Ltd.
- 10.5.1 Company Overview
- 10.5.2 Company Snapshot
- 10.5.3 Financial Overview
- 10.5.4 Product Listing
- 10.5.5 Entropy
- 10.6 LUCID KOREA LTD.
- 10.6.1 Company Overview
- 10.6.2 Company Snapshot
- 10.6.3 Financial Overview
- 10.6.4 Product Listing
- 10.6.5 Entropy
- 10.7 Alcon Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Snapshot
- 10.7.3 Financial Overview
- 10.7.4 Product Listing
- 10.7.5 Entropy
- 10.8 HOYA VISION CARE COMPANY
- 10.8.1 Company Overview
- 10.8.2 Company Snapshot
- 10.8.3 Financial Overview
- 10.8.4 Product Listing
- 10.8.5 Entropy
- 10.9 SynergEyes
- 10.9.1 Company Overview
- 10.9.2 Company Snapshot
- 10.9.3 Financial Overview
- 10.9.4 Product Listing
- 10.9.5 Entropy
- 10.10 SightGlass Vision, Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Snapshot
- 10.10.3 Financial Overview
- 10.10.4 Product Listing
- 10.10.5 Entropy
- 10.11 Ophtec BV
- 10.11.1 Company Overview
- 10.11.2 Company Snapshot
- 10.11.3 Financial Overview
- 10.11.4 Product Listing
- 10.11.5 Entropy
- 10.12 STAAR SURGICAL
- 10.12.1 Company Overview
- 10.12.2 Company Snapshot
- 10.12.3 Financial Overview
- 10.12.4 Product Listing
- 10.12.5 Entropy
- 10.13 Mark'ennovy
- 10.13.1 Company Overview
- 10.13.2 Company Snapshot
- 10.13.3 Financial Overview
- 10.13.4 Product Listing
- 10.13.5 Entropy
- 10.14 SCHWIND eye-tech-solutions
- 10.14.1 Company Overview
- 10.14.2 Company Snapshot
- 10.14.3 Financial Overview
- 10.14.4 Product Listing
- 10.14.5 Entropy
- 10.15 Euclid Systems Corporation
- 10.15.1 Company Overview
- 10.15.2 Company Snapshot
- 10.15.3 Financial Overview
- 10.15.4 Product Listing
- 10.15.5 Entropy
- 10.16 NIDEK USA, Inc.
- 10.16.1 Company Overview
- 10.16.2 Company Snapshot
- 10.16.3 Financial Overview
- 10.16.4 Product Listing
- 10.16.5 Entropy
- 10.17 Esahorus srl
- 10.17.1 Company Overview
- 10.17.2 Company Snapshot
- 10.17.3 Financial Overview
- 10.17.4 Product Listing
- 10.17.5 Entropy
- 10.18 Falco lenses AG
- 10.18.1 Company Overview
- 10.18.2 Company Snapshot
- 10.18.3 Financial Overview
- 10.18.4 Product Listing
- 10.18.5 Entropy
- 11. KOL Views
- 12. Project Approach
- 13. About DelveInsight
- 14. Disclaimer & Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.